FQ-393

N/A

Report date: 2022/01/07 15:40:37
NME

Base Information

Drug NameFQ-393
Drug Alias NameFQ-393
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransitional endoplasmic reticulum ATPase inhibitors
TargetsTransitional endoplasmic reticulum ATPase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCapital Medical University
China Registration ClassN/A

Develop Information

Active CompaniesCapital Medical University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A